{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:13Z","timestamp":1789632193785,"version":"build-2803163510"},"reference-count":131,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15827","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:10:26Z","timestamp":1787310626000},"page":"1-16","source":"Crossref","is-referenced-by-count":0,"title":["Colorectal cancer and tumor vaccines (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Jianshuang","family":"Ma","sequence":"first","affiliation":[{"name":"Department of General Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congming","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"key20260917101316_b1-ol-32-4-15827","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20260917101316_b2-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"key20260917101316_b3-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/bjs.11486","article-title":"Demographic trends in the incidence of young-onset colorectal cancer: A population-based study","volume":"107","author":"Chambers","year":"2020","journal-title":"Br J Surg"},{"key":"key20260917101316_b4-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"795972","DOI":"10.3389\/fimmu.2022.795972","article-title":"Neoadjuvant immunotherapy for MSI-H\/dMMR locally advanced colorectal cancer: New strategies and unveiled opportunities","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"key20260917101316_b5-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: Harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"key20260917101316_b6-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1158\/1078-0432.CCR-13-2671","article-title":"Is the \u20183+3\u2019 dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design","volume":"20","author":"Rahma","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20260917101316_b7-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced prostate cancer: Treatment advances and future directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer"},{"key":"key20260917101316_b8-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40364-024-00692-9","article-title":"mRNA cancer vaccines from bench to bedside: A new era in cancer immunotherapy","volume":"12","author":"Shariati","year":"2024","journal-title":"Biomark Res"},{"key":"key20260917101316_b9-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID-19 vaccines: The status and perspectives in delivery points of view","volume":"170","author":"Chung","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"key20260917101316_b10-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.3390\/ijms252011256","article-title":"Cancer vaccines: Recent insights and future directions","volume":"25","author":"Malacopol","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260917101316_b11-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"key":"key20260917101316_b12-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e10588","DOI":"10.1002\/btm2.10588","article-title":"Cancer vaccines in the clinic","volume":"9","author":"Janes","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"key20260917101316_b13-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/pharmaceutics15071969","article-title":"Cancer vaccines: From the state of the art to the most promising frontiers in the treatment of colorectal cancer","volume":"15","author":"Martinis","year":"2023","journal-title":"Pharmaceutics"},{"key":"key20260917101316_b14-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e1083669","DOI":"10.1080\/2162402X.2015.1083669","article-title":"Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma","volume":"5","author":"Vandenberk","year":"2015","journal-title":"Oncoimmunology"},{"key":"key20260917101316_b15-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.csbj.2020.08.001","article-title":"Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform","volume":"18","author":"Ahmed","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"key20260917101316_b16-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/1871520615666150907094139","article-title":"Combination of DC vaccine and conventional chemotherapeutics","volume":"16","author":"Dong","year":"2016","journal-title":"Anticancer Agents Med Chem"},{"key":"key20260917101316_b17-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12032-020-01433-2","article-title":"B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer","volume":"37","author":"Lian","year":"2020","journal-title":"Med Oncol"},{"key":"key20260917101316_b18-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1111\/jcmm.70057","article-title":"Dendritic cell-derived lncRNAs in patients with acute coronary syndrome","volume":"28","author":"Wang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"key20260917101316_b19-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"105374","DOI":"10.1016\/j.phrs.2020.105374","article-title":"Dendritic cell vaccine therapy for colorectal cancer","volume":"164","author":"Wooster","year":"2021","journal-title":"Pharmacol Res"},{"key":"key20260917101316_b20-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fimmu.2019.00766","article-title":"Personalized dendritic cell vaccines-recent breakthroughs and encouraging clinical results","volume":"10","author":"Mastelic-Gavillet","year":"2019","journal-title":"Front Immunol"},{"key":"key20260917101316_b21-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1613332","DOI":"10.3389\/fonc.2025.1613332","article-title":"Vaccine therapies for glioma: Clinical frontiers and potential breakthrough","volume":"15","author":"Xing","year":"2025","journal-title":"Front Oncol"},{"key":"key20260917101316_b22-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"615704","DOI":"10.3389\/fonc.2021.615704","article-title":"Glioma stem cells as immunotherapeutic targets: Advancements and challenges","volume":"11","author":"Piper","year":"2021","journal-title":"Front Oncol"},{"key":"key20260917101316_b23-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ymthe.2021.09.011","article-title":"COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models","volume":"30","author":"Conforti","year":"2022","journal-title":"Mol Ther"},{"key":"key20260917101316_b24-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10529-023-03383-x","article-title":"Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: A review","volume":"45","author":"Danaeifar","year":"2023","journal-title":"Biotechnol Lett"},{"key":"key20260917101316_b25-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-019-1154-7","article-title":"Cancer DNA vaccines: Current preclinical and clinical developments and future perspectives","volume":"38","author":"Lopes","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101316_b26-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1158\/2159-8290.CD-24-1196","article-title":"Immunogenicity and efficacy of personalized adjuvant mRNA cancer vaccines","volume":"14","author":"Berraondo","year":"2024","journal-title":"Cancer Discov"},{"key":"key20260917101316_b27-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s12276-023-01118-6","article-title":"Understanding nucleic acid sensing and its therapeutic applications","volume":"55","author":"Kong","year":"2023","journal-title":"Exp Mol Med"},{"key":"key20260917101316_b28-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4161\/hv.22661","article-title":"mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic","volume":"9","author":"Van Lint","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key20260917101316_b29-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ame2.70018","article-title":"Respiratory virus mRNA vaccines: mRNA Design, clinical studies, and future challenges","volume":"8","author":"Zheng","year":"2025","journal-title":"Animal Model Exp Med"},{"key":"key20260917101316_b30-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine","volume":"386","author":"Moreira","year":"2022","journal-title":"N Engl J Med"},{"key":"key20260917101316_b31-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"21782","DOI":"10.1039\/C9NR05475H","article-title":"Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant","volume":"11","author":"Yang","year":"2019","journal-title":"Nanoscale"},{"key":"key20260917101316_b32-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1448489","DOI":"10.3389\/fimmu.2024.1448489","article-title":"Emerging prospects of mRNA cancer vaccines: Mechanisms, formulations, and challenges in cancer immunotherapy","volume":"15","author":"Laila","year":"2024","journal-title":"Front Immunol"},{"key":"key20260917101316_b33-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/vaccines11061043","article-title":"Sulfated lactosyl archaeol archaeosome-adjuvanted vaccine formulations targeting rabbit hemorrhagic disease virus are immunogenic and efficacious","volume":"11","author":"Akache","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"key20260917101316_b34-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00109-022-02199-y","article-title":"Current and future direction in treatment of HPV-related cervical disease","volume":"100","author":"Khairkhah","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"key20260917101316_b35-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e2414779","DOI":"10.1002\/advs.202414779","article-title":"Therapeutic black phosphorus nanosheets elicit neutrophil response for enhanced tumor suppression","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101316_b36-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s10989-021-10287-9","article-title":"Integrated multi-omics, virtual screening and molecular docking analysis of methicillin-resistant staphylococcus aureus USA300 for the identification of potential therapeutic targets: An in-silico approach","volume":"27","author":"Rahman","year":"2021","journal-title":"Int J Pept Res Ther"},{"key":"key20260917101316_b37-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2174\/1389450120666190619121658","article-title":"Personalized peptide-based vaccination for treatment of colorectal cancer: Rational and progress","volume":"20","author":"Parizadeh","year":"2019","journal-title":"Curr Drug Targets"},{"key":"key20260917101316_b38-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"eado5937","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"Ben-Akiva","year":"2025","journal-title":"Sci Immunol"},{"key":"key20260917101316_b39-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fimmu.2020.01012","article-title":"CD40 accelerates the antigen-specific stem-like memory CD8(+) T cells formation and human papilloma virus (HPV)-Positive tumor eradication","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"key20260917101316_b40-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/ITT.S273327","article-title":"Therapeutic vaccines for HPV-Associated malignancies","volume":"9","author":"Smalley Rumfield","year":"2020","journal-title":"Immunotargets Ther"},{"key":"key20260917101316_b41-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","article-title":"COVID-19 vaccine frontrunners and their nanotechnology design","volume":"14","author":"Chung","year":"2020","journal-title":"ACS Nano"},{"key":"key20260917101316_b42-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"NPJ Vaccines"},{"key":"key20260917101316_b43-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.omtm.2019.06.011","article-title":"Temporary reduction of membrane CD4 with the antioxidant MnTBAP is sufficient to prevent immune responses induced by gene transfer","volume":"14","author":"Da Rocha","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"key20260917101316_b44-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmi.2020.12.032","article-title":"Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure","volume":"27","author":"Eyal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key20260917101316_b45-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.ebiom.2026.106230","article-title":"Development and preclinical evaluation of KDTV001, an adenovirus 5-vectored trivalent HPV therapeutic vaccine targeting HPV16\/18\/52","volume":"126","author":"Dai","year":"2026","journal-title":"EBioMedicine"},{"key":"key20260917101316_b46-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3892\/or.2015.4299","article-title":"Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo","volume":"34","author":"Horiuchi","year":"2015","journal-title":"Oncol Rep"},{"key":"key20260917101316_b47-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"15330338241232554","DOI":"10.1177\/15330338241232554","article-title":"A novel necroptosis-related signature can predict prognosis and chemotherapy sensitivity in multiple myeloma","volume":"23","author":"Jiang","year":"2024","journal-title":"Technol Cancer Res Treat"},{"key":"key20260917101316_b48-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12672-024-01117-7","article-title":"The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer","volume":"15","author":"Chuang","year":"2024","journal-title":"Discov Oncol"},{"key":"key20260917101316_b49-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.3748\/wjg.v24.i48.5418","article-title":"Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens","volume":"24","author":"Wagner","year":"2018","journal-title":"World J Gastroenterol"},{"key":"key20260917101316_b50-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: An emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol Cancer"},{"key":"key20260917101316_b51-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1111\/1759-7714.15126","article-title":"Recent advances in neoantigen vaccines for treating non-small cell lung cancer","volume":"14","author":"Su","year":"2023","journal-title":"Thorac Cancer"},{"key":"key20260917101316_b52-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s40001-024-02057-2","article-title":"Parasites revive hope for cancer therapy","volume":"29","author":"Eissa","year":"2024","journal-title":"Eur J Med Res"},{"key":"key20260917101316_b53-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1016\/j.vaccine.2015.08.096","article-title":"Suppression of T cell responses in the tumor microenvironment","volume":"33","author":"Frey","year":"2015","journal-title":"Vaccine"},{"key":"key20260917101316_b54-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijms20143403","article-title":"Vaccinations for colorectal cancer: Progress, strategies, and novel adjuvants","volume":"20","author":"Jiang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20260917101316_b55-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.3390\/ijms241411434","article-title":"Friend or foe? Locoregional therapies and immunotherapies in the current hepatocellular treatment landscape","volume":"24","author":"Young","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260917101316_b56-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2020.00327","article-title":"Adjuvant screen identifies synthetic DNA-Encoding Flt3L and CD80 immunotherapeutics as candidates for enhancing anti-tumor T cell responses","volume":"11","author":"Thorne","year":"2020","journal-title":"Front Immunol"},{"key":"key20260917101316_b57-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/17435889.2025.2486930","article-title":"Advances in cancer nanovaccines: A focus on colorectal cancer","volume":"20","author":"Ghazizadeh","year":"2025","journal-title":"Nanomedicine (Lond)"},{"key":"key20260917101316_b58-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.actbio.2024.12.003","article-title":"Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models","volume":"192","author":"Shi","year":"2025","journal-title":"Acta Biomater"},{"key":"key20260917101316_b59-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e70148","DOI":"10.1002\/ctm2.70148","article-title":"ZSH-2208: A novel retinoid with potent anti-tumour effects on ESCC stem cells via RAR\u03b3-TNFAIP3 axis","volume":"15","author":"Chen","year":"2025","journal-title":"Clin Transl Med"},{"key":"key20260917101316_b60-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal immune response in biology, disease prevention and treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20260917101316_b61-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e2309770","DOI":"10.1002\/advs.202309770","article-title":"All-trans-retinoic acid-adjuvanted mRNA vaccine induces mucosal anti-tumor immune responses for treating colorectal cancer","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101316_b62-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/vaccines12010026","article-title":"Oral administration of cancer vaccines: Challenges and future perspectives","volume":"12","author":"Gambirasi","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"key20260917101316_b63-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.3390\/nano12193410","article-title":"Mesenchymal stem cell-mediated deep tumor delivery of gold nanorod for photothermal therapy","volume":"12","author":"Yun","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"key20260917101316_b64-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9010001","article-title":"Advances in oral subunit vaccine design","volume":"9","author":"Van der Weken","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"key20260917101316_b65-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41385-019-0159-z","article-title":"Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines","volume":"12","author":"Davitt","year":"2019","journal-title":"Mucosal Immunol"},{"key":"key20260917101316_b66-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"21170","DOI":"10.1021\/jacs.5c06776","article-title":"Montmorillonite-based oral vaccine for colorectal cancer immunotherapy through mucosal immune activation","volume":"147","author":"Yang","year":"2025","journal-title":"J Am Chem Soc"},{"key":"key20260917101316_b67-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e41354","DOI":"10.1016\/j.heliyon.2024.e41354","article-title":"Immunotherapy in colorectal cancer: Statuses and strategies","volume":"11","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"key20260917101316_b68-ol-32-4-15827","first-page":"491","article-title":"Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison","volume":"22","author":"Zhang","year":"2022","journal-title":"Bioact Mater"},{"key":"key20260917101316_b69-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.vaccine.2005.01.015","article-title":"Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: A prospective study of medical and economic benefits","volume":"23","author":"Uyl-de Groot","year":"2005","journal-title":"Vaccine"},{"key":"key20260917101316_b70-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21147\/j.issn.1000-9604.2018.02.03","article-title":"Impact of 5-Fu\/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine","volume":"30","author":"Hong","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"key20260917101316_b71-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jare.2025.06.089","article-title":"Recent research progress and clinical status of immunotherapy for colorectal cancer","volume":"82","author":"Huo","year":"2026","journal-title":"J Adv Res"},{"key":"key20260917101316_b72-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"942235","DOI":"10.3389\/fimmu.2022.942235","article-title":"Colorectal cancer vaccines: The current scenario and future prospects","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol"},{"key":"key20260917101316_b73-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00280-018-3690-9","article-title":"Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer","volume":"82","author":"Taflin","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20260917101316_b74-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1586\/14760584.4.3.259","article-title":"Vaccines in cancer: GVAX, a GM-CSF gene vaccine","volume":"4","author":"Nemunaitis","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"key20260917101316_b75-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/cam4.2763","article-title":"A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer","volume":"9","author":"Yarchoan","year":"2020","journal-title":"Cancer Med"},{"key":"key20260917101316_b76-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: Current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J Hematol Oncol"},{"key":"key20260917101316_b77-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1039\/C9LC00811J","article-title":"A microfluidic platform for functional testing of cancer drugs on intact tumor slices","volume":"20","author":"Rodriguez","year":"2020","journal-title":"Lab Chip"},{"key":"key20260917101316_b78-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/biomedicines4020010","article-title":"Cancer vaccines in ovarian cancer: How can we improve?","volume":"4","author":"Martin Lluesma","year":"2016","journal-title":"Biomedicines"},{"key":"key20260917101316_b79-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.3390\/cancers13225819","article-title":"Vaccines as priming tools for T cell therapy for epithelial cancers","volume":"13","author":"Kandalaft","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20260917101316_b80-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2429846","DOI":"10.1080\/2162402X.2024.2429846","article-title":"Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesis","volume":"13","author":"Bourguignon","year":"2024","journal-title":"Oncoimmunology"},{"key":"key20260917101316_b81-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajo.2014.07.014","article-title":"Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients","volume":"158","author":"Bol","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key20260917101316_b82-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40425-018-0405-z","article-title":"A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis","volume":"6","author":"Rodriguez","year":"2018","journal-title":"J Immunother Cancer"},{"key":"key20260917101316_b83-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"4325874","DOI":"10.1155\/2018\/4325874","article-title":"Recent development and clinical application of cancer vaccine: Targeting neoantigens","volume":"2018","author":"Pan","year":"2018","journal-title":"J Immunol Res"},{"key":"key20260917101316_b84-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-22-3168","article-title":"Randomized, double-blind, placebo-controlled trial of MUC1 peptide vaccine for prevention of recurrent colorectal adenoma","volume":"29","author":"Schoen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"key20260917101316_b85-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.conctc.2019.100409","article-title":"First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)","volume":"16","author":"Pham","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"key20260917101316_b86-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s11605-018-4060-y","article-title":"Novel vaccine targeting colonic adenoma: A pre-clinical model","volume":"23","author":"Pham","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"key20260917101316_b87-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.3390\/cancers12113481","article-title":"Precision approaches in the management of colorectal cancer: Current evidence and latest advancements towards individualizing the treatment","volume":"12","author":"Shuford","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20260917101316_b88-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"102405","DOI":"10.1016\/j.ctrv.2022.102405","article-title":"The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines","volume":"107","author":"Wei","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"key20260917101316_b89-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","article-title":"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: Phase 1 trial interim results","volume":"28","author":"Palmer","year":"2022","journal-title":"Nat Med"},{"key":"key20260917101316_b90-ol-32-4-15827","article-title":"Merck Moderna and Merck present 5-Year data for intismeran autogene in combination with KEYTRUDA\u00ae (pembrolizumab) in patients with high-risk stage III\/IV melanoma following complete resection at the 2026 ASCO annual meeting","year":"2026"},{"key":"key20260917101316_b91-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40425-019-0576-2","article-title":"Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients","volume":"7","author":"Snook","year":"2019","journal-title":"J Immunother Cancer"},{"key":"key20260917101316_b92-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00262-012-1248-y","article-title":"Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects","volume":"61","author":"Osada","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"key20260917101316_b93-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.21037\/atm-21-491","article-title":"Current status of intralesional agents in treatment of malignant melanoma","volume":"9","author":"Zawit","year":"2021","journal-title":"Ann Transl Med"},{"key":"key20260917101316_b94-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/v17030414","article-title":"The application of DNA viruses to biotechnology","volume":"17","author":"Schieferecke","year":"2025","journal-title":"Viruses"},{"key":"key20260917101316_b95-ol-32-4-15827","first-page":"vdab027","article-title":"Therapeutic cancer vaccines for pediatric malignancies: Advances, challenges, and emerging technologies","volume":"3","author":"Olsen","year":"2021","journal-title":"Neurooncol Adv"},{"key":"key20260917101316_b96-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e3292","DOI":"10.1002\/btpr.3292","article-title":"Development of virus-like particles-based vaccines against coronaviruses","volume":"38","author":"Yong","year":"2022","journal-title":"Biotechnol Prog"},{"key":"key20260917101316_b97-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/ijms24032288","article-title":"Zebrafish cancer avatars: A translational platform for analyzing tumor heterogeneity and predicting patient outcomes","volume":"24","author":"Al-Hamaly","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260917101316_b98-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.3390\/ijms26104559","article-title":"Signature gene mutations in colorectal cancer: Potential neoantigens for cancer vaccines","volume":"26","author":"Yoon","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260917101316_b99-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"102024","DOI":"10.1016\/j.xcrm.2025.102024","article-title":"Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"key20260917101316_b100-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2021.10.012","article-title":"Experimental challenges to modeling prostate cancer heterogeneity","volume":"524","author":"Flores-T\u00e9llez","year":"2022","journal-title":"Cancer Lett"},{"key":"key20260917101316_b101-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1451003","DOI":"10.3389\/fimmu.2024.1451003","article-title":"Extracellular vesicles & Co: Scaring immune cells in the TME since ever","volume":"15","author":"Rodolfo","year":"2024","journal-title":"Front Immunol"},{"key":"key20260917101316_b102-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1515390","DOI":"10.3389\/fimmu.2025.1515390","article-title":"Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity","volume":"16","author":"Mentucci","year":"2025","journal-title":"Front Immunol"},{"key":"key20260917101316_b103-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"key20260917101316_b104-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"key20260917101316_b105-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/A:1008160817560","article-title":"Safety for vaccine(e)s","volume":"34","author":"Merten","year":"2000","journal-title":"Cytotechnology"},{"key":"key20260917101316_b106-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-9966-33-30","article-title":"Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme","volume":"33","author":"Chiarion Sileni","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101316_b107-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1158863","DOI":"10.3389\/fonc.2023.1158863","article-title":"Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics","volume":"13","author":"Gu","year":"2023","journal-title":"Front Oncol"},{"key":"key20260917101316_b108-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40249-021-00878-5","article-title":"Safety of SARS-CoV-2 vaccines: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Chen","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"key20260917101316_b109-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/healthcare10122535","article-title":"What motivates people to receive continuous COVID-19 vaccine booster shots? An expectation confirmation theory perspective","volume":"10","author":"Liu","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"key20260917101316_b110-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fchem.2020.00284","article-title":"Carbohydrate conjugates in vaccine developments","volume":"8","author":"Lang","year":"2020","journal-title":"Front Chem"},{"key":"key20260917101316_b111-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/vim.2005.18.689","article-title":"Timing of retroviral infection influences anamnestic immune response in vaccinated primates","volume":"18","author":"Anderson","year":"2005","journal-title":"Viral Immunol"},{"key":"key20260917101316_b112-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"eadt0341","DOI":"10.1126\/sciadv.adt0341","article-title":"A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis","volume":"11","author":"Kang","year":"2025","journal-title":"Sci Adv"},{"key":"key20260917101316_b113-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/13543784.2021.1896702","article-title":"Neoantigen vaccine platforms in clinical development: Understanding the future of personalized immunotherapy","volume":"30","author":"Supabphol","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"key20260917101316_b114-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12890-025-03791-x","article-title":"PD-1\/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: A real-world study and nomogram for survival prognosis","volume":"25","author":"Mao","year":"2025","journal-title":"BMC Pulm Med"},{"key":"key20260917101316_b115-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"10760296211056648","DOI":"10.1177\/10760296211056648","article-title":"An update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations","volume":"28","author":"Kantarcioglu","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"key20260917101316_b116-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1177085","DOI":"10.3389\/fimmu.2023.1177085","article-title":"Radiotherapy combined with immune checkpoint inhibitors in locally advanced\/metastatic esophageal squamous cell carcinoma: Clinical trials, efficacy and future directions","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"key20260917101316_b117-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"djv001","DOI":"10.1093\/jnci\/djv001","article-title":"Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer","volume":"107","author":"Scurr","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"key20260917101316_b118-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/diseases10030060","article-title":"Emerging trends in immunotherapy for cancer","volume":"10","author":"Mishra","year":"2022","journal-title":"Diseases"},{"key":"key20260917101316_b119-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13148-026-02081-5","article-title":"Epigenetic modulation to overcome immune suppression in pancreatic cancer","volume":"18","author":"Drndakova","year":"2026","journal-title":"Clin Epigenetics"},{"key":"key20260917101316_b120-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jcmgh.2021.08.005","article-title":"Form follows function for local immune responses in pancreatic cancer","volume":"12","author":"Means","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"key20260917101316_b121-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e7804","DOI":"10.7717\/peerj.7804","article-title":"Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer","volume":"7","author":"Chen","year":"2019","journal-title":"PeerJ"},{"key":"key20260917101316_b122-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10238-024-01436-7","article-title":"Personalized neoantigen cancer vaccines: Current progression, challenges and a bright future","volume":"24","author":"Wu","year":"2024","journal-title":"Clin Exp Med"},{"key":"key20260917101316_b123-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14216\/kjco.24326","article-title":"Developing cancer vaccine with carcinoembryonic antigen and IGF-1R as immunostimulants using immunoinformatics approach","volume":"21","author":"Ezediuno","year":"2025","journal-title":"Korean J Clin Oncol"},{"key":"key20260917101316_b124-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41587-024-02420-y","article-title":"A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy","volume":"43","author":"Huber","year":"2025","journal-title":"Nat Biotechnol"},{"key":"key20260917101316_b125-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"e1652","DOI":"10.1002\/ctm2.1652","article-title":"Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study","volume":"14","author":"Guo","year":"2024","journal-title":"Clin Transl Med"},{"key":"key20260917101316_b126-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41421-021-00360-4","article-title":"Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discov"},{"key":"key20260917101316_b127-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1038\/s41467-023-38946-z","article-title":"Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat Commun"},{"key":"key20260917101316_b128-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"1473145","DOI":"10.3389\/fimmu.2024.1473145","article-title":"Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"key20260917101316_b129-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/14760584.2021.1935248","article-title":"Challenges targeting cancer neoantigens in 2021: A systematic literature review","volume":"20","author":"Chen","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"key20260917101316_b130-ol-32-4-15827","first-page":"894","article-title":"Colorectal cancer, liver metastases and biotherapies","volume":"9","author":"Osei-Bordom","year":"2021","journal-title":"Biomedicine"},{"key":"key20260917101316_b131-ol-32-4-15827","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2017.02.010","article-title":"The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells","volume":"45","author":"Ramachandran","year":"2017","journal-title":"Semin Cancer Biol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:14:12Z","timestamp":1789629252000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":131,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15827","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}